A study by researchers at the UCLA Jonsson Comprehensive Cancer Center found that using percutaneous image guided needle based thermal ablation is a safe and effective adjunctive therapy for the local control of metastatic gynecologic cancers throughout lungs, liver, soft tissues in the abdomen and pelvis and bones—and in patients with advanced localized cancers unresponsive to systemic therapy.
With a growing backlog at NIH and Columbia University’s grants getting canceled over alleged antisemitism, where does that leave NCI-designated cancer centers?
